Fanouriakis, A. Adamichou, C. Koutsoviti, S. Panopoulos, S. Staveri, C. Klagou, A. Tsalapaki, C. Pantazi, L. Konsta, S. Mavragani, C.P. Dimopoulou, D. Ntali, S. Katsikas, G. Boki, K.A. Vassilopoulos, D. Konstantopoulou, P. Liossis, S.-N. Elezoglou, A. Tektonidou, M. Sidiropoulos, P. Erden, A. Sfikakis, P.P. Bertsias, G. Boumpas, D.T., Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study, Seminars in Arthritis and Rheumatism, (48), 467-474, 2018, W.B. Saunders, 0049-0172